The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Market Value Of The Brain Mapping Instruments Market Projected To Expand During 2026–2030?
The brain mapping instruments market size has seen significant growth in recent years. It is anticipated to expand from $2.42 billion in 2025 to $2.58 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.6%. This past growth can be attributed to several factors, including the increase in neurological disorder diagnosis programs, the rising adoption of EEG and CT-based brain mapping systems, the early integration of neuroimaging tools in hospitals and research centers, the broadening of brain activity monitoring in clinical neurology, and increased investment in neuroscience research infrastructure.
The brain mapping instruments market is poised for robust expansion over the coming years, with its valuation projected to reach $3.33 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This anticipated growth during the forecast period is fueled by several factors, including the escalating demand for fMRI and PET-based functional brain mapping, the greater adoption of hybrid and high-resolution imaging systems, an increase in the use of non-invasive mapping solutions in outpatient environments, the expanding incorporation of multimodal brain analysis tools, and the broadening utility of brain mapping within precision medicine and neurotherapeutics. Key developments expected during this timeframe encompass the increasing implementation of sophisticated neuroimaging and brain activity monitoring technologies, the wider deployment of brain mapping instruments in clinical diagnosis and the formulation of treatment strategies, the extended application of brain mapping across neuroscience and cognitive research, a growing inclination towards non-invasive and patient-centric brain mapping techniques, and an emphasis on improving imaging precision, data integrity, and diagnostic effectiveness.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18270&type=smp
What Core Drivers Are Transforming The Brain Mapping Instruments Market?
The rising occurrence of neurological conditions is anticipated to drive the expansion of the brain mapping instrument market in the future. These disorders encompass conditions impacting the brain, spinal cord, and nerves, manifesting as issues like impaired movement, reduced cognitive function, and sensory disturbances, with examples such as Alzheimer’s, Parkinson’s, epilepsy, multiple sclerosis, and stroke. The growing incidence of neurological disorders can be attributed to factors such as an aging population, increased urbanization, evolving lifestyles, advancements in diagnostic methods, and environmental alongside infectious risk factors. In both clinical settings and research, brain mapping instruments are crucial for gaining profound understanding of neurological disorders and formulating individualized treatment plans. For example, data from March 2023, reported by the Alzheimer’s Association, a US-based non-profit voluntary health organization, indicated that approximately 6.7 million Americans aged 65 and older in the United States were affected by Alzheimer’s dementia, which falls under neurological disorders. Furthermore, projections suggest that by 2060, the population aged 65 and older suffering from Alzheimer’s dementia will rise to 13.8 million. Consequently, the rising prevalence of neurological disorders serves as a key driver for the expansion of the brain mapping instrument market.
What Segment Categories Are Evaluated In The Brain Mapping Instruments Market Study?
The brain mapping instruments market covered in this report is segmented –
1) By Product: Computed Axial Tomography (CAT), Positron Emission Tomography, Electroencephalography (EEG), Functional Near-Infrared Spectroscopy (FNIRS), Functional Magnetic Resonance Imaging (FMRI), Other Products
2) By Procedure: Devices For Invasive Procedures, Devices For Non-invasive Procedures
3) By End User: Hospitals, Ambulatory Centers
Subsegments:
1) By Computed Axial Tomography (CAT): Conventional CT Scanners, High-Resolution CT Scanners, Portable CT Scanners
2) By Positron Emission Tomography (PET): PET Scanners (Standalone), Hybrid PET/CT Scanners, PET/MRI Scanners
3) By Electroencephalography (EEG): Digital EEG Systems, Ambulatory EEG Systems, Video EEG Monitoring Systems
4) By Functional Near-Infrared Spectroscopy (FNIRS): Continuous Wave Fnirs Systems, Frequency Domain Fnirs Systems, Hybrid Fnirs Systems
5) By Functional Magnetic Resonance Imaging (FMRI): Resting-State Fmri, Task-Based Fmri, High-Field MRI Systems
6) By Other Products: Magnetoencephalography (MEG) Systems, Near-Infrared Spectroscopy (NIRS) Devices, Transcranial Magnetic Stimulation (TMS) Systems
What Trends Are Affecting The Growth Of The Brain Mapping Instruments Market?
Major companies operating in the brain mapping instruments market are concentrating on adaptive neuromodulation systems with sensing capabilities, such as BrainSense-enabled closed-loop deep brain stimulation (DBS), which integrates real-time brain signal detection to tailor stimulation therapy. BrainSense technology functions as a neuro-interface integrated into DBS systems, recording local field potentials (LFPs) from specific brain regions, processing these signals, and dynamically adjusting electrical stimulation based on a patient’s neural activity, thereby optimizing therapeutic effects and minimizing side effects. For instance, in February 2025, Medtronic, a US-based medical-technology company, unveiled its BrainSense Adaptive DBS system following FDA approval, offering features like real-time self-adjusting stimulation, a BrainSense Electrode Identifier to quickly determine the optimal electrode contact, and personalized closed-loop therapy that adapts both in clinical settings and during a patient’s daily life.
Which Organizations Are Operating Within The Brain Mapping Instruments Market?
Major companies operating in the brain mapping instruments market are Siemens Healthineers, GE Healthcare, Philips Healthcare, Elekta AB, Nihon Kohden Corporation, Brainlab AG, Natus Medical Incorporated, Hitachi Medical Systems, Canon Medical Systems Corporation, Compumedics Limited, Medtronic PLC, Magstim Company Limited, EB Neuro S.p.A., Brain Products GmbH, Soterix Medical Inc., Rogue Research Inc., NIRx Medical Technologies LLC, Neurosoft, Artinis Medical Systems, Gowerlabs Ltd.
Access The Complete Brain Mapping Instruments Market Report:
https://www.thebusinessresearchcompany.com/report/brain-mapping-instruments-global-market-report
Which Geographic Region Represents The Largest Brain Mapping Instruments Market Share?
North America was the largest region in the brain mapping instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain mapping instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Brain Mapping Instruments Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=18270&type=smp
Browse Through More Reports Similar to the Global Brain Mapping Instruments Market 2026, By The Business Research Company
Brain And Neuroimaging Devices Market Report 2026
Brain Monitoring Market Report 2026
https://www.thebusinessresearchcompany.com/report/brain-monitoring-global-market-report
Brain Health Supplements Market Report 2026
https://www.thebusinessresearchcompany.com/report/brain-health-supplements-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model